IP Verse

Medimmune patent opposition analysis

Get complete Patent Opposition Report for Medimmune

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Medimmune opposed by its competitors

Explore Medimmune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3218406	Oct 2, 2024	Binding Molecules Specific For Cd73 And Uses Thereof	2
EP3157629	Oct 5, 2022	Methods Of Cancer Treatment With Antagonists Against Pd-1 And Pd-L1 In Combination With Radiation Therapy	1
EP1942939	Jul 7, 2021	Interleukin-13 Antibody Composition	1
EP3329018	Mar 31, 2021	Methods For Treating Hepcidin-Mediated Disorders	1
EP2997036	Mar 3, 2021	Purification Of Recombinantly Produced Polypeptides	4
EP2935268	Feb 17, 2021	Pyrrolobenzodiazepines And Conjugates Thereof	1
EP2624859	Mar 1, 2017	Factor Ii And Fibrinogen For Treatment Of Haemostatic Disorders	1

Top competitors of Medimmune

GLAXOSMITHKLINE

OETKE

STRAWMAN